59 studies found for:    Open Studies | "Arthritis, Psoriatic"
Show Display Options
Rank Status Study
1 Recruiting Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
Condition: Arthritis, Psoriatic
Intervention: Drug: Tofacitinib
2 Not yet recruiting Study of Application of Power Doppler Ultrasonography (PDUS) to Measure Response to Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)
Condition: Arthritis, Psoriatic
Interventions: Drug: AIN457 (secukinumab);   Drug: Placebo
3 Recruiting BI 655066 Compared to Placebo in Patients With Active Psoriatic Arthritis
Condition: Arthritis, Psoriatic
Interventions: Drug: Placebo;   Drug: BI 655066 high dose;   Drug: BI 655066 medium high dose;   Drug: BI 655066 medium dose;   Drug: BI 655066 low dose
4 Recruiting A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics
Condition: Psoriatic Arthritis
Intervention: Other: No Intervention
5 Unknown  Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Conditions: Rheumatoid Arthritis;   Psoriatic Arthritis;   Ankylosing Spondylitis;   Hypertension
Interventions: Drug: Etanercept;   Drug: Adalimumab;   Drug: Certolizumab;   Drug: Infliximab
6 Recruiting Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis;   Crohn´s Disease;   Ulcerative Colitis;   Plaque Psoriasis
Intervention:
7 Unknown  Psoriatic Arthritis Treat to Target vs. Usual Care
Condition: Psoriatic Arthritis (PsA)
Intervention: Other: Intensive Care
8 Recruiting Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Biological: Secukinumab
9 Recruiting Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Drug: Etanercept + Oral Methotrexate;   Drug: Etanercept + Placebo for Methotrexate;   Drug: Oral Methotrexate + Placebo for Etanercept
10 Recruiting Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment (WPAI))
Condition: Psoriatic Arthritis
Intervention:
11 Not yet recruiting Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Interventions: Biological: Secukinumab;   Biological: Adalimumab
12 Unknown  Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Open label H.P. Acthar Gel
13 Recruiting Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)
Condition: Psoriatic Arthritis
Interventions: Drug: Guselkumab;   Drug: Ustekinumab;   Drug: Placebo
14 Recruiting A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: No Intervention
15 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention:
16 Recruiting Efficacy of Golimumab in Combination With Methotrexate (Mtx) Versus Mtx Monotherapy, in Improving Dactylitis, in Mtx naïve Psoriatic Arthritis Patients
Condition: Psoriatic Arthritis
Interventions: Drug: Golimumab;   Drug: Methotrexate;   Drug: Placebo
17 Not yet recruiting Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site
Conditions: Psoriatic Arthritis;   Axial Spondyloarthritis;   Enthesitis
Interventions: Biological: AIN457/Secukinumab;   Drug: AIN457/Secukinumab Placebo
18 Recruiting Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
Conditions: Psoriatic Arthritis;   Psoriasis;   Impaired Glucose Tolerance;   Type 2 Diabetes
Interventions: Drug: liraglutide;   Other: Placebo
19 Recruiting PET/CT in Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Radiation: FDG-PET/CT scan
20 Not yet recruiting Treatment With Apremilast in Patients With Psoriatic Arthritis
Condition: Psoriatic Arthritis
Intervention: Drug: Treatment with Apremilast

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years